MRNANov 19, 2026
Moderna: Can the Vaccine Business Fund Its Next Phase of Growth?
MRNA's ambitious oncology investments and expanding vaccine portfolio drive growth, but rising costs and uncertain revenues test its financial recovery.
Read on zacks.com